You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
中康科技實現AI技術三大突破:DeepSeek深度融合、核心技術升級、華為昇騰技術認證
格隆匯 02-24 09:34
在數字化浪潮席捲全球的當下,人工智能(AI)技術已成為推動各行業進步的核心力量。作為健康醫療領域的創新先鋒,中康科技憑藉其強大的數據技術實力和前瞻性的AI戰略部署,實現了AI技術的三大突破,為健康產業的智能化轉型注入了強大動力。中康科技自主研發的卓睦鳥醫療大模型在2025年年初完成與DeepSeek的深度融合,致力於打造“以患者為中心”的數智化全生命週期健康管理體系。DeepSeek R1與卓睦鳥醫療大模型的深度融合,構建了一套智能輔助決策系統。該系統融合了卓睦鳥醫療大模型的病歷數據治理能力和DeepSeek R1的推理優勢,卓睦鳥大模型憑藉對51個核心病種、20.5萬藥品數據的精準解析能力,可精準抽取患者病史關鍵信息(如過敏史、用藥記錄等),而DeepSeek R1的深度推理引擎則實時整合最新NCCN指南文獻對患者病情進行全面評估。同時提供科學的治療建議、精準的藥物療程推薦及完善的不良反應管理建議,形成一套完整、清晰、規範的診療方案。中康科技自主研發的卓睦鳥醫療大模型已完成首輪推理訓練,多項關鍵技術得以突破,核心技術邁入了新的階段。在技術層面,該模型在參數規模、訓練數據量、推理效率等關鍵指標上均取得了顯著突破。這些突破不僅提升了模型的性能,更為其在多個垂直領域的應用落地奠定了堅實基礎。通過華為昇騰芯片兼容性、GDPR/等保三級合規性、10萬QPS高併發等23項嚴苛測試,卓睦鳥大模型已通過華為昇騰技術認證,成為行業權威認可的AI解決方案供應商。這意味着從三甲醫院的PET-CT影像分析到縣域衞生院的電子病歷質控,模型均可實現“端-邊-雲”協同計算。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account